Biochemical Reagent
-
BA5470 RP101988Summary: RP101442 is the major active metabolite of Ozanimod. - BA6494 MK2-IN-3Summary: MK2-IN-3 is a potent and selective inhibitor.
- BA6495 MMI-0100Summary: MMI-0100 is a cell-permeable peptide inhibitor that inhibits mitogen-activated protein kinase-activated protein kinase II.
- BA6496 NST-628Summary: NST-628 is a MAPK pathway molecular gel with blood-brain barrier permeability that inhibits phosphorylation and activation.
- BA6497 MS432Summary: MS432 is an innovative, highly selective, degradation agent based on PD0325901 and ligands.
- BA6498 TrametiglueSummary: A derivative.
- BA6500 MS934Summary: MS934 is a new and improved degradation agent for VHL recruitment.
- BA6501 NedometinibSummary: Nedometinib is a tyrosine kinase inhibitor that is targeted.
- BA6502 GSK1790627Summary: GSK1790627 is an N-deacetyl metabolite.
- BA6503 PD0325901-O-C2-dioxolaneSummary: PD0325901-O-C2-dioxolane contains an inhibitor PD0325901 major fraction.